Scarica l'app Stockscreener
26.38
2.57%
0.66
Precedente Chiudi:
$25.72
Aprire:
$26.09
Volume 24 ore:
302.05K
Relative Volume:
1.45
Capitalizzazione di mercato:
$330.46M
Reddito:
-
Utile/perdita netta:
$-51.74M
Rapporto P/E:
-5.936
EPS:
-4.4441
Flusso di cassa netto:
$-44.57M
1 W Prestazione:
+6.16%
1M Prestazione:
-7.24%
6M Prestazione:
+85.12%
1 anno Prestazione:
+209.99%
Intervallo 1D:
$25.27
$29.50
Intervallo di 1 settimana:
$22.01
$29.50
Portata 52W:
$4.90
$35.62
Forte Biosciences Inc Stock (FBRX) Company Profile
Nome
Forte Biosciences Inc
Settore
Industria
Telefono
(310) 618-6994
Indirizzo
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
26.38 | 322.19M | 0 | -51.74M | -44.57M | -4.4441 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-25 | Iniziato | Evercore ISI | Outperform |
| 2025-08-18 | Iniziato | Guggenheim | Buy |
| 2025-01-21 | Iniziato | TD Cowen | Buy |
| 2024-04-08 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Aggiornamento | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Downgrade | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Downgrade | Truist | Buy → Hold |
| 2021-05-14 | Iniziato | B. Riley Securities | Buy |
| 2021-03-26 | Iniziato | Citigroup | Buy |
| 2020-08-28 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Iniziato | Truist | Buy |
Mostra tutto
Forte Biosciences Inc Borsa (FBRX) Ultime notizie
Technical Reactions to FBRX Trends in Macro Strategies - Stock Traders Daily
Rally Mode: Is Forte Biosciences Inc a top pick in the sectorEarnings Miss & Growth Oriented Trade Recommendations - baoquankhu1.vn
Forte Biosciences Inc expected to post a loss of $1.21 a shareEarnings Preview - TradingView
Pullback Watch: Will Forte Biosciences Inc announce a stock splitQuarterly Performance Summary & High Win Rate Trade Tips - baoquankhu1.vn
If You Invested $1,000 in Forte Biosciences Inc (FBRX) - Stock Titan
FBRX Stock Price, Quote & Chart | FORTE BIOSCIENCES INC (NASDAQ:FBRX) - ChartMill
Forte Biosciences (FBRX) Projected to Post Earnings on Friday - MarketBeat
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat
Aug Fed Impact: Does Forte Biosciences Inc have pricing power2026 Price Targets & Growth Focused Investment Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - The Joplin Globe
Mink Brook Asset Management LLC Buys 42,419 Shares of Forte Biosciences, Inc. $FBRX - MarketBeat
New hires at Forte Biosciences get options on 25,000 shares - Stock Titan
Trading the Move, Not the Narrative: (FBRX) Edition - Stock Traders Daily
History Review: Can Forte Biosciences Inc maintain its current growth rateGap Up & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
FBRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
FBRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Bank Watch: Can LOKV lead its sector in growth2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
Can Forte Biosciences Inc. stock beat analyst upgradesEarnings Beat & Growth Focused Stock Pick Reports - Naître et grandir
Can Forte Biosciences Inc. stock maintain growth trajectoryWeekly Loss Report & Technical Confirmation Alerts - Naître et grandir
Portfolio Update: Can MKTW withstand a market correction2025 Analyst Calls & Community Verified Trade Alerts - baoquankhu1.vn
Forte Biosciences (FBRX) Price Target Increased by 16.98% to 53.30 - MSN
Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules - marketscreener.com
Vitiligo Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com
Stock Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat
Biotech Forte Biosciences hands 100,000 stock options to new hires - Stock Titan
Celiac Disease Market: Expanding Revenue Landscape to 2034 – DelveInsight | Zedira, Dr. Falk Pharma, Takeda, ImmunoGenX, Provention Bio, Sanofi, Topas Therapeutics GmbH, Pfizer - StreetInsider
(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
FBRX PE Ratio & Valuation, Is FBRX Overvalued - Intellectia AI
Forte Biosciences (FBRX) Raised to Buy: Key Information You Need - Bitget
Forte Biosciences (FBRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Pullback Watch: Is Forte Biosciences Inc a top pick in the sector2025 Risk Factors & Low Volatility Stock Suggestions - baoquankhu1.vn
Is Forte Biosciences Inc. a top pick in the sectorWeekly Stock Summary & Weekly Watchlist for Hot Stocks - mfd.ru
Will Forte Biosciences Inc. benefit from rate cutsQuarterly Portfolio Report & Stepwise Swing Trade Plans - mfd.ru
Price-Driven Insight from (FBRX) for Rule-Based Strategy - Stock Traders Daily
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat
Analyst Downgrade: Is Forte Biosciences Inc stock a good dividend stockCEO Change & Growth Focused Entry Reports - baoquankhu1.vn
We Think Forte Biosciences (NASDAQ:FBRX) Can Afford To Drive Business Growth - Yahoo Finance
Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ - openPR.com
Growth Recap: How much upside does KWESST Micro Systems Inc Equity Warrant havePortfolio Performance Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Why Forte Biosciences Inc. stock is popular among millennialsJuly 2025 Reactions & Daily Profit Maximizing Tips - mfd.ru
Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Decrease in Short Interest - MarketBeat
Why Airbnb Inc. stock is favored by top institutionsJuly 2025 Institutional & Reliable Price Breakout Alerts - mfd.ru
Celiac Disease Clinical Trial Pipeline Gains Momentum As 25+ Companies Advance Novel Therapies Toward Market Entry: Delveinsight Teva Pharmaceutical Industries, Barinthus Biotherapeutics, Topas - Menafn.com
Will Forte Biosciences Inc. stock deliver better than expected guidanceQuarterly Earnings Report & Proven Capital Preservation Tips - mfd.ru
Is Forte Biosciences Inc. stock a good choice for value investors2025 Technical Patterns & AI Forecast for Swing Trade Picks - mfd.ru
Can Forte Biosciences Inc. maintain its current growth rateDollar Strength & AI Powered Buy/Sell Recommendations - mfd.ru
Institutional Owners May Ignore Forte Biosciences, Inc.'s (NASDAQ:FBRX) Recent US$87m Market Cap Decline as Longer-term Profits Stay in the Green - 富途牛牛
Does Forte Biosciences Inc. have pricing powerPortfolio Performance Summary & Growth Focused Stock Pick Reports - mfd.ru
Forte Biosciences Inc Azioni (FBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):